Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003877 · ClinicalTrials.gov registry record · Phase 1

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target
3
Study locations

NCT00003877 is a Phase 1 study of Breast Cancer that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003877, a Phase 1 study of Breast Cancer, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

RATIONALE: Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. It is not yet known whether Stromagen improves the success of stem cell transplantation in women with breast cancer. PURPOSE: Randomized phase I/II trial to study the effectiveness of Stromagen during stem cell transplantation following chemotherapy in treating women with metastatic breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • DRUG carboplatin
  • DRUG cyclophosphamide
  • DRUG paclitaxel
  • BIOLOGICAL filgrastim
  • DRUG thiotepa

Study Locations (3)

Michigan

  • Barbara Ann Karmanos Cancer Institute - Detroit

New York

  • Roswell Park Cancer Institute - Buffalo

Ohio

  • Ireland Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 1998-09
Est. Completion 2000-12
Phase Phase 1

Sponsor

Roswell Park Cancer Institute

365 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003877

The ClinicalTrials.gov registry entry for NCT00003877 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which carboplatin is the first listed.

NCT00003877 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT00003877 about?

NCT00003877 is a clinical study titled "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer". RATIONALE: Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. It is not yet known whether Stromagen improves the success of stem cell transplantation in women with breast cancer. PURPOSE: Randomized phase I/II trial to study the ef...

What is the current status of trial NCT00003877?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 1998-09. Estimated completion is 2000-12.

What conditions does trial NCT00003877 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00003877?

The interventions under investigation include: carboplatin (DRUG), cyclophosphamide (DRUG), paclitaxel (DRUG), filgrastim (BIOLOGICAL), thiotepa (DRUG).

Who is sponsoring clinical trial NCT00003877?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003877 being conducted?

This trial has 3 study locations across Michigan, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.